This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Angiogenic switch is a prerequisite for the tumor progression and presumably for the acquisition of an invasive property. Mobilization of vascular smooth muscle cells (SMCs) is the key event for new blood vessel formation. Studies have demonstrated that PDGF, secreted by various tumor cells including breast, is an important regulator of vascular smooth muscle cells motility. Recently, we have shown that NRP-1 expressed differentially in Vascular SMCs. However, the role of NRP-1 in regulation of vascular SMCs motility has not yet been fully established. We anticipate that NRP-1 may contribute in the mobilization of vascular SMCs that could be mediated through tumor cell-derived-PDGF. To test the hypothesis, we determined if PDGF physically interacts with NRP-1 to potentiate the migration of vascular SMCs. PDGF secretion level was determined by western blot analysis in different tumor cell-derived media. To determine the stimulatory effect of PDGF, cells were grown in basal media with or without PDGF in the Boyden chamber and migration was determined by counting the Giemsa stained cells. NRP-1 expression in vascular SMCs with or without PDGF was established by RT-PCR and western blot analysis. The importance of NRP-1 in PDGF-induced migration was established by silencing of NRP-1 using shRNA. Interaction of PDGF and NRP-1 was determined by immunoprecipitation/immunobloting. The studies indicate that breast tumor cells-secreted B-forms of PDGF augments the migration and NRP-1 expression in vascular SMCs. Silencing of NRP-1 by shRNA blocks the PDGF-induced migration of SMCs. B-forms of PDGF physically interacts with NRP-1 of SMCs to exert the migratory response. NRP-1 is a major component in PDGF signaling pathway in vascular SMCs migration. Next, we will determine the down-stream signaling molecules associated with this event. In particular, we will determine the role of PDGF receptors in PDGF-NRP-1 mediated vascular SMCs migration.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR015563-07
Application #
7381086
Study Section
Special Emphasis Panel (ZRR1-RI-8 (01))
Project Start
2006-05-01
Project End
2007-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
7
Fiscal Year
2006
Total Cost
$162,000
Indirect Cost
Name
University of Kansas Lawrence
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
076248616
City
Lawrence
State
KS
Country
United States
Zip Code
66045
Subramanian, Chitra; Grogan, Patrick T; Opipari, Valerie P et al. (2018) Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of N-myc and suppression of Akt/mTOR/NF-?B activation. Oncotarget 9:14509-14523
Ishiguro, Susumu; Kawabata, Atsushi; Zulbaran-Rojas, Alejandro et al. (2018) Co-treatment with a C1B5 peptide of protein kinase C? and a low dose of gemcitabine strongly attenuated pancreatic cancer growth in mice through T cell activation. Biochem Biophys Res Commun 495:962-968
He, Chenchen; Duan, Shaofeng; Dong, Liang et al. (2017) Characterization of a novel p110?-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells. Prostate 77:1187-1198
White, Peter T; Subramanian, Chitra; Zhu, Qing et al. (2016) Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion. Surgery 159:142-51
Ohta, Naomi; Ishiguro, Susumu; Kawabata, Atsushi et al. (2015) Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes. PLoS One 10:e0123756
Li, Benyi; Thrasher, James Brantley; Terranova, Paul (2015) Glycogen synthase kinase-3: a potential preventive target for prostate cancer management. Urol Oncol 33:456-63
Ishiguro, Susumu; Yoshimura, Kiyoshi; Tsunedomi, Ryouichi et al. (2015) Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice. Cancer Biol Ther 16:307-16
Standard, Joseph; Jiang, Yu; Yu, Miao et al. (2014) Reduced signaling of PI3K-Akt and RAS-MAPK pathways is the key target for weight-loss-induced cancer prevention by dietary calorie restriction and/or physical activity. J Nutr Biochem 25:1317-23
Peterson, Kenneth R; Costa, Flávia C; Fedosyuk, Halyna et al. (2014) A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies. PLoS One 9:e107006
Kong, Bo; Huang, Jiansheng; Zhu, Yan et al. (2014) Fibroblast growth factor 15 deficiency impairs liver regeneration in mice. Am J Physiol Gastrointest Liver Physiol 306:G893-902

Showing the most recent 10 out of 240 publications